Daniel R. Chevallard
Chief Financial Officer · 1 filing · Latest: Mar 27, 2026
LENZ Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LENZ | Daniel R. Chevallard | Chief Financial Officer | Mar 27, 2026 | Purchase | $8.57 | 7,500 | $64.3K | 12,886 |